Differentiation of bosniak categories IIF and III cystic masses: What radiologists should know

Journal of Computer Assisted Tomography

Volumn 34, Issue 6, 2010, Pages 847-854

  Park, Byung Kwan ^a   Kim, Chan Kyo ^a   Kim, Eun Young ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

computed tomography; cyst; kidney; neoplasm; renal cell carcinoma

Indexed keywords

COMPUTERIZED TOMOGRAPHY; UROLOGY;

COMPUTED TOMOGRAPHY; CONTRAST MATERIAL; CYST; CYSTIC MASS; IMAGING FEATURES; KIDNEY; NEOPLASM; RENAL CELL CARCINOMA;

MAGNETIC RESONANCE;

ABSCESS; CANCER GRADING; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; HEMORRHAGIC CYSTITIS; HUMAN; IMAGE ENHANCEMENT; IMAGE QUALITY; IMAGING SYSTEM; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY TUMOR; OXYGEN BLOOD LEVEL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIOLOGIST; REVIEW; TUMOR CLASSIFICATION; TUMOR VOLUME;

EID: 78650469280     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/RCT.0b013e3181ee9e02     Document Type: Review

References (52)

1. Bosniak MA. The current radiological approach to renal cysts. Radiology. 1986;158:1-10.
2. Israel GM, Bosniak MA. Follow-up CT of moderately complex cystic lesions of the kidney (Bosniak category IIF). AJR Am J Roentgenol. 2003;181:627-633.
3. Cloix P, Martin X, Pangaud C, et al. Surgical management of complex renal cysts: A series of 32 cases. J Urol. 1996;156:28-30.
4. Siegel CL, McFarland EG, Brink JA, et al. CT of cystic renal masses: Analysis of diagnostic performance and interobserver variation. AJR Am J Roentgenol. 1997;169:813-818.
5. Curry NS, Cochran ST, Bissada NK. Cystic renal masses: Accurate Bosniak classification requires adequate renal CT. AJR Am J Roentgenol. 2000;175:339-342.
6. Aronson S, Frazier HA, Baluch JD, et al. Cystic renal masses: Usefulness of the Bosniak classification. Urol Radiol. 1991;13:83-90.
7. Briguori C, Tavano D, Colombo A. Contrast agentYassociated nephrotoxicity. Prog Cardiovasc Dis. 2003;45:493-503.
8. McCullough PA, Wolyn R, Rocher LL, et al. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. Am J Med. 1997;103:368-375.
9. Grobner T. GadoliniumVa specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant. 2006;21:1104-1108.
10. Marckmann P, Skov L, Rossen K, et al. Nephrogenic systemic fibrosis: Suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol. 2006;17:2359-2362.
11. Silverman SG, Israel GM, Herts BR, et al. Management of the incidental renal mass. Radiology. 2008;249:16-31.
12. Israel GM, Bosniak MA. Calcification in cystic renal masses: Is it important in diagnosis? Radiology. 2003;226:47-52.
13. Israel GM, Hindman N, Bosniak MA. Evaluation of cystic renal masses: Comparison of CT and MR imaging by using the Bosniak classification system. Radiology. 2004;231:365-371.
14. Warren KS, McFarlane J. The Bosniak classification of renal cystic masses. BJU Int. 2005;95:939-942.
15. Israel GM, Bosniak MA. How I do it: Evaluating renal masses. Radiology. 2005;236:441-450.
16. Bae KT, Heiken JP, Siegel CL, et al. Renal cysts: Is attenuation artifactually increased on contrast-enhanced CT images? Radiology. 2000;216:792-796.
17. Birnbaum BA, Hindman N, Lee J, et al. Multi-detector row CT attenuation measurements: Assessment of intra- and interscanner variability with an anthropomorphic body CT phantom. Radiology. 2007;242:109-119.
18. Birnbaum BA, Hindman N, Lee J, et al. Renal cyst pseudoenhancement: Influence of multidetector CT reconstruction algorithm and scanner type in phantom model. Radiology. 2007;244: 767-775.
19. Maki DD, Birnbaum BA, Chakraborty DP, et al. Renal cyst pseudoenhancement: Beam-hardening effects on CT numbers. Radiology. 1999;213:468-472.
20. Koga S, Nishikido M, Inuzuka S, et al. An evaluation of Bosniak's radiological classification of cystic renal masses. BJU Int. 2000;86:607-609.
21. Lang EK, Macchia RJ, Gayle B, et al. CT-guided biopsy of indeterminate renal cystic masses (Bosniak 3 and 2F): Accuracy and impact on clinical management. Eur Radiol. 2002;12:2518-2524.
22. Harisinghani MG, Maher MM, Gervais DA, et al. Incidence of malignancy in complex cystic renal masses (Bosniak category III): Should imaging-guided biopsy precede surgery? AJR Am J Roentgenol. 2003;180:755-758.
23. Rybicki FJ, Shu KM, Cibas ES, et al. Percutaneous biopsy of renal masses: Sensitivity and negative predictive value stratified by clinical setting and size of masses. AJR Am J Roentgenol. 2003;180: 1281-1287.
24. Silverman SG, Gan YU, Mortele KJ, et al. Renal masses in the adult patient: The role of percutaneous biopsy. Radiology. 2006;240:6-22.
25. Bosniak MA. The small (less than or equal to 3.0 cm) renal parenchymal tumor: Detection, diagnosis, and controversies. Radiology. 1991;179:307-317.
26. Bosniak MA. Diagnosis and management of patients with complicated cystic lesions of the kidney. AJR Am J Roentgenol. 1997;169:819-821.
27. Park BK, Kim B, Kim SH, et al. Assessment of cystic renal masses based on Bosniak classification: Comparison of CT and contrast-enhanced US. Eur J Radiol. 2007;61:310-314.
28. Ascenti G, Mazziotti S, Zimbaro G, et al. Complex cystic renal masses: Characterization with contrast-enhanced US. Radiology. 2007; 243:158-165.
29. Quaia E, Bertolotto M, Cioffi V, et al. Comparison of contrast-enhanced sonography with unenhanced sonography and contrast-enhanced CT in the diagnosis of malignancy in complex cystic renal masses. AJR Am J Roentgenol. 2008;191:1239-1249.
30. Hecht EM, Israel GM, Krinsky GA, et al. Renal masses: Quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging. Radiology. 2004;232: 373-378.
31. Papanicolaou N, Pfister RC. Acute renal infections. Radiol Clin North Am. 1996;34:965-995.
32. Browne RF, Zwirewich C, Torreggiani WC. Imaging of urinary tract infection in the adult. Eur Radiol. 2004;14(suppl 3):E168-E183.
33. Silver IM, Boag AH, Soboleski DA. Best cases from the AFIP: Multilocular cystic renal tumor: Cystic nephroma. Radiographics. 2008;28:1221-1225; discussion 1225-1226.
34. Madewell JE, Goldman SM, Davis CJ Jr, et al. Multilocular cystic nephroma: A radiographic-pathologic correlation of 58 patients. Radiology. 1983;146:309-321.
35. Jonisch AI, Rubinowitz AN, Mutalik PG, et al. Can high-attenuation renal cysts be differentiated from renal cell carcinoma at unenhanced CT? Radiology. 2007;243:445-450.
36. Correas JM, Claudon M, Tranquart F, et al. The kidney: Imaging with microbubble contrast agents. Ultrasound Q. 2006;22:53-66.
37. Gupta RK, Sinha U, Cloughesy TF, et al. Inverse correlation between choline magnetic resonance spectroscopy signal intensity and the apparent diffusion coefficient in human glioma. Magn Reson Med. 1999;41:2-7.
38. Le Bihan D. Diffusion/perfusion MR imaging of the brain: From structure to function. Radiology. 1990;177:328-329.
39. Chandarana H, Lee VS. Renal functional MRI: Are we ready for clinical application? AJR Am J Roentgenol. 2009;192:1550-1557.
40. Nasu K, Kuroki Y, Tsukamoto T, et al. Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: Imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic grade. AJR Am J Roentgenol. 2009; 193:438-444.
41. Schraml C, Schwenzer NF, Martirosian P, et al. Diffusion-weighted MRI of advanced hepatocellular carcinoma during sorafenib treatment: Initial results. AJR Am J Roentgenol. 2009;193: W301-W307.
42. Taouli B, Thakur RK, Mannelli L, et al. Renal lesions: Characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging. Radiology. 2009;251:398-407.
43. Kim S, Jain M, Harris AB, et al. T1 hyperintense renal lesions: Characterization with diffusion-weighted MR imaging versus contrast-enhanced MR imaging. Radiology. 2009;251: 796-807.
44. Kim CK, Park BK, Lee HM, et al. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: Preliminary results. Invest Radiol. 2007;42: 842-847.
45. Park BK, Lee HM, Kim CK, et al. Lesion localization in patients with a previous negative transrectal ultrasound biopsy and persistently elevated prostate specific antigen level using diffusion-weighted imaging at three Tesla before rebiopsy. Invest Radiol. 2008;43:789-793.
46. Thulborn KR, Waterton JC, Matthews PM, et al. Oxygenation dependence of the transverse relaxation time of water protons in whole blood at high field. Biochim Biophys Acta. 1982;714:265-270.
47. dos Santos EA, Li LP, Ji L, et al. Early changes with diabetes in renal medullary hemodynamics as evaluated by fiberoptic probes and BOLD magnetic resonance imaging. Invest Radiol. 2007;42:157-162.
48. Palm F, Cederberg J, Hansell P, et al. Reactive oxygen species cause diabetes-induced decrease in renal oxygen tension. Diabetologia. 2003;46:1153-1160.
49. Ries M, Basseau F, Tyndal B, et al. Renal diffusion and BOLD MRI in experimental diabetic nephropathy. Blood oxygen level-dependent. J Magn Reson Imaging. 2003;17:104-113.
50. Textor SC, Glockner JF, Lerman LO, et al. The use of magnetic resonance to evaluate tissue oxygenation in renal artery stenosis. J Am Soc Nephrol. 2008;19:780-788.
51. Sadowski EA, Fain SB, Alford SK, et al. Assessment of acute renal transplant rejection with blood oxygen level-dependent MR imaging: Initial experience. Radiology. 2005;236:911-919.
52. Epstein FH, Veves A, Prasad PV. Effect of diabetes on renal medullary oxygenation during water diuresis. Diabetes Care. 2002;25:575-578.